AWM
ASTH icon

Abound Wealth Management’s Astrana Health ASTH Stock Holding History

Abound Wealth Management’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-7
Closed -$216 – 1407
2023
Q3 		$216 Hold
7
– – ﹤0.01% 1093
2023
Q2 		$222 Buy
+7
New +$240 ﹤0.01% 1138

Other funds holding ASTH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Abound Wealth Management's ASTH Position: Q4 2023 in Review

Abound Wealth Management sold out of Astrana Health (ASTH) in Q4 2023, closing a stake of 7 shares — an estimated $216 sold.

Abound Wealth Management first reported a position in ASTH in Q2 2023 and held it in 2 quarters. The position peaked at $222 in Q2 2023. 143 funds tracked by Wall St. Rank hold ASTH as of Q4 2023.

  • Abound Wealth Management reported no remaining Astrana Health position as of Q4 2023 after selling out during the quarter.
  • Abound Wealth Management sold 7 Astrana Health shares in Q4 2023, an estimated $216.
  • Abound Wealth Management first reported a position in Astrana Health in Q2 2023 and held it in 2 quarters.
  • Abound Wealth Management's Astrana Health position peaked at $222 in Q2 2023.
  • 143 funds tracked by Wall St. Rank held Astrana Health as of Q4 2023.

Based on Abound Wealth Management's 13F filing for Q4 2023, filed 8 Aug 2024.